Back to today’s briefing

Story perspectives

FDA Considers Approval of Controversial Animal-Derived Thyroid Drugs

8/15/2025

45 3

Summary

Story summary

The FDA expressed concerns over unapproved animal-derived thyroid medications due to safety risks and hormone inconsistencies.
In response to public backlash, FDA Commissioner Marty Makary proposed potential approval for desiccated thyroid extract.
Experts caution that unregulated animal-derived pills may pose health risks, though some advocate for their use in patients unresponsive to synthetic treatments.

1 of 1

Story summary

The FDA expressed concerns over unapproved animal-derived thyroid medications due to safety risks and hormone inconsistencies.
In response to public backlash, FDA Commissioner Marty Makary proposed potential approval for desiccated thyroid extract.
Experts caution that unregulated animal-derived pills may pose health risks, though some advocate for their use in patients unresponsive to synthetic treatments.